Advertisement

Optical Coherence Tomography in the Catheterization Laboratory

  • Luca Di Vito
  • Laura Gatto
  • Francesco Prati
Chapter

Abstract

X-ray coronary angiography remains the gold standard for assessment of atherosclerotic lesions of coronary arteries and for guidance of coronary intervention. However, angiography only depicts the luminal narrowings caused by coronary plaques, without showing the structures located beneath the endothelial surface within the vessel walls.

Intravascular imaging modalities are now available allowing direct visualization of coronary artery walls and thus overcoming angiographic limitations. Optical coherence tomography (OCT) is a novel imaging technique that uses infrared light to assess atherosclerotic plaques and stented segments with extreme accuracy. Compared with intravascular ultrasound (IVUS), OCT has better spatial resolution at the expense of the penetration depth.

This chapter reviews the current role of OCT in the assessment of coronary artery disease and the clinical outcome of OCT-guided percutaneous coronary intervention (PCI). Detailed visualization of the superficial lipid pool, thin fibrous cap, and inflammatory cells allows OCT to precisely identify vulnerable plaque with thin-cap fibroatheroma. Recent data support the emerging clinical role of OCT-guided PCI as a means to reduce the incidence of adverse coronary events.

References

  1. 1.
    Spaan JA, Piek JJ, Hoffman JI, Siebes M. Physiological basis of clinically used coronary hemodynamic indices. Circulation. 2006;113:446–55.CrossRefPubMedGoogle Scholar
  2. 2.
    Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31:401–15.CrossRefPubMedGoogle Scholar
  3. 3.
    Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T, Barlis P, Tearney GJ, Jang IK, Arbustini E, Bezerra HG, Ozaki Y, Bruining N, Dudek D, Radu M, Erglis A, Motreff P, Alfonso F, Toutouzas K, Gonzalo N, Tamburino C, Adriaenssens T, Pinto F, Serruys PW, Di Mario C, Expert’s OCT Review Document. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J. 2012;33:2513–20.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551–5.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Raber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J, Siegel E, Sonoda S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T, Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59:1058–72.CrossRefPubMedGoogle Scholar
  6. 6.
    Suh WM, Seto AH, Margey RJ, Cruz-Gonzalez I, Jang IK. Intravascular detection of the vulnerable plaque. Circ Cardiovasc Imaging. 2011;4:169–78.CrossRefPubMedGoogle Scholar
  7. 7.
    Takarada S, Imanishi T, Liu Y, Ikejima H, Tsujioka H, Kuroi A, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Kubo T, Nakamura N, Hirata K, Tanaka A, Mizukoshi M, Akasaka T. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv. 2010;75:202–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Albertucci M. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. EuroIntervention. 2007;3:365–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Ozaki Y, Kitabata H, Tsujioka H, Hosokawa S, Kashiwagi M, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Takarada S, Kubo T, Kimura K, Tanaka A, Hirata K, Mizukoshi M, Imanishi T, Akasaka T. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circ J. 2012;76:922–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Yoon JH, Di Vito L, Moses JW, Fearon WF, Yeung AC, Zhang S, Bezerra HG, Costa MA, Jang IK. Feasibility and safety of the second-generation, frequency domain optical coherence tomography (FD-OCT): a multicenter study. J Invasive Cardiol. 2012;24:206–9.PubMedGoogle Scholar
  11. 11.
    Guagliumi G, Bezerra HG, Sirbu V, Ikejima H, Musumeci G, Biondi-Zoccai G, Lortkipanidze N, Fiocca L, Capodanno D, Wang W, Tahara S, Vassileva A, Matiashvili A, Valsecchi O, Costa MA. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv. 2012;5:30–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Suzuki N, Guagliumi G, Bezerra HG, Sirbu V, Rosenthal N, Musumeci G, Aprile A, Wang H, Kyono H, Tahara S, Simon DI, Rollins A, Costa MA. The impact of an eccentric intravascular ImageWire during coronary optical coherence tomography imaging. EuroIntervention. 2011;6:963–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Imola F, Mallus MT, Ramazzotti V, Manzoli A, Pappalardo A, Di Giorgio A, Albertucci M, Prati F. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention. 2010;6:575–81.CrossRefPubMedGoogle Scholar
  14. 14.
    Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Halpern EF, Bouma BE. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003;107:113–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Di Vito L, Imola F, Gatto L, Romagnoli E, Limbruno U, Marco V, Picchi A, Micari A, Albertucci M, Prati F. Limitations of OCT in identifying and quantifying lipid components. An in-vivo comparison study with IVUS-NIRS. EuroIntervention. 2017;13(3):303–11.CrossRefPubMedGoogle Scholar
  16. 16.
    Yonetsu T, Kato K, Uemura S, Kim BK, Jang Y, Kang SJ, Park SJ, Lee S, Kim SJ, Jia H, Vergallo R, Abtahian F, Tian J, Hu S, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Yu B, Kakuta T, Jang IK. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ Cardiovasc Imaging. 2013;6:665–73.CrossRefPubMedGoogle Scholar
  17. 17.
    Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5:433–40.CrossRefPubMedGoogle Scholar
  18. 18.
    Niccoli G, Giubilato S, Di Vito L, Leo A, Cosentino N, Pitocco D, Marco V, Ghirlanda G, Prati F, Crea F. Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J. 2013;34:729–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Tanigawa J, Barlis P, Di Mario C. Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. Circ J. 2008;72:157–60.CrossRefPubMedGoogle Scholar
  20. 20.
    Tenaglia AN, Buller CE, Kisslo KB, Phillips HR, Stack RS, Davidson CJ. Intracoronary ultrasound predictors of adverse outcomes after coronary artery interventions. J Am Coll Cardiol. 1992;20:1385–90.CrossRefPubMedGoogle Scholar
  21. 21.
    Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62:1748–58.CrossRefPubMedGoogle Scholar
  22. 22.
    Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L, Biondi-Zoccai G, Halperin J, Fuster V, Ozaki Y, Narula J. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6:283–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Gonzalo N, Escaned J, Alfonso F, Nolte C, Rodriguez V, Jimenez-Quevedo P, Banuelos C, Fernandez-Ortiz A, Garcia E, Hernandez-Antolin R, Macaya C. Morphometric assessment of coronary stenosis relevance with optical coherence tomography: a comparison with fractional flow reserve and intravascular ultrasound. J Am Coll Cardiol. 2012;59:1080–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Jamil Z, Tearney G, Bruining N, Sihan K, van Soest G, Ligthart J, van Domburg R, Bouma B, Regar E. Interstudy reproducibility of the second generation, Fourier domain optical coherence tomography in patients with coronary artery disease and comparison with intravascular ultrasound: a study applying automated contour detection. Int J Cardiovasc Imaging. 2013;29:39–51.CrossRefPubMedGoogle Scholar
  25. 25.
    Gerber R, Colombo A. Does IVUS guidance of coronary interventions affect outcome? A prime example of the failure of randomized clinical trials. Catheter Cardiovasc Interv. 2008;71:646–54.CrossRefPubMedGoogle Scholar
  26. 26.
    Mintz GS, Weissman NJ. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol. 2006;48:421–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008;29:1851–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Witzenbichler B, Maehara A, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Stuckey TD, Mazzaferri EL Jr, Xu K, Parise H, Mehran R, Mintz GS, Stone GW. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Circulation. 2014;129:463–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478–92.CrossRefPubMedGoogle Scholar
  30. 30.
    Prati F, Di Vito L, Biondi-Zoccai G, Occhipinti M, La Manna A, Tamburino C, Burzotta F, Trani C, Porto I, Ramazzotti V, Imola F, Manzoli A, Materia L, Cremonesi A, Albertucci M. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta Contro l’Infarto–Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention. 2012;8:823–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Meneveau N, Souteyrand G, Motreff P, Caussin C, Amabile N, Ohlmann P, Morel O, Lefrançois Y, Descotes-Genon V, Silvain J, Braik N, Chopard R, Chatot M, Ecarnot F, Tauzin H, Van Belle E, Belle L, Schiele F. Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (Does Optical Coherence Tomography Optimize Results of Stenting). Circulation. 2016;134:906–17.CrossRefPubMedGoogle Scholar
  32. 32.
    Prati F, Romagnoli E, Burzotta F, Limbruno U, Gatto L, La Manna A, Versaci F, Marco V, Di Vito L, Imola F, Paoletti G, Trani C, Tamburino C, Tavazzi L, Mintz GS. Clinical impact of OCT findings during PCI: the CLI-OPCI II study. JACC Cardiovasc Imaging. 2015;8:1297–305.CrossRefPubMedGoogle Scholar
  33. 33.
    Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW, et al. Circulation. 2010;122:1077–84.CrossRefPubMedGoogle Scholar
  34. 34.
    Gutierrez-Chico JL, Wykrzykowska J, Nuesch E, van Geuns RJ, Koch KT, Koolen JJ, di Mario C, Windecker S, van Es GA, Gobbens P, Juni P, Regar E, Serruys PW. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv. 2012;5:20–9, S21–28.CrossRefPubMedGoogle Scholar
  35. 35.
    Porto I, Di Vito L, Burzotta F, Niccoli G, Trani C, Leone AM, Biasucci LM, Vergallo R, Limbruno U, Crea F. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography. Circ Cardiovasc Interv. 2012;5:89–96, S81–86.CrossRefPubMedGoogle Scholar
  36. 36.
    Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Limbruno U, Versaci F, Fabbiocchi F, Di Giorgio A, Marco V, Ramazzotti V, Di Vito L, Trani C, Porto I, Boi A, Tavazzi L, Mintz GS. Clinical impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome: the CLI-OPCI ACS substudy (Centro per la Lotta Contro L’Infarto–Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome). Circ Cardiovasc Interv. 2016;9(12):e003726.CrossRefPubMedGoogle Scholar
  37. 37.
    Di Giorgio A, Capodanno D, Ramazzotti V, Imola F, Mallus MT, Stazi F, Paoletti G, Biondi-Zoccai G, Tamburino C, Prati F. Optical coherence tomography guided in-stent thrombus removal in patients with acute coronary syndromes. Int J Cardiovasc Imaging. 2013;29:989–96.CrossRefPubMedGoogle Scholar
  38. 38.
    Jolly SS, James S, Džavík V, Cairns JA, Mahmoud KD, Zijlstra F, Yusuf S, Olivecrona GK, Renlund H, Gao P, Lagerqvist B, Alazzoni A, Kedev S, Stankovic G, Meeks B, Frøbert O. Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: Thrombectomy Trialists Collaboration. Circulation. 2017;135:143–52.CrossRefPubMedGoogle Scholar
  39. 39.
    Prati F, Romagnoli E, Limbruno U, Pawlowski T, Fedele S, Gatto L, Di Vito L, Pappalardo A, Ramazzotti V, Picchi A, Trivisonno A, Materia L, Pfiatkosky P, Paoletti G, Marco V, Tavazzi L, Versaci F, Stone G. Randomized evaluation of intralesion vs intracoronary abciximab and aspiration thrombectomy in patients with STEMI: the COCTAIL II trial. Am Heart J. 2015;170:1116–23.CrossRefPubMedGoogle Scholar
  40. 40.
    Ali Z, Maehara A, Genereux P, Shlofmitz RA, Fabbiocci F, Nazif TM, Guagliumi G, Meraj PM, Alfonso A, Samadt H, Akasaka T, Carlson EB, Leesar MA, Matsumara M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388:2618–28.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Luca Di Vito
    • 1
    • 2
  • Laura Gatto
    • 1
    • 2
  • Francesco Prati
    • 1
    • 2
  1. 1.CardiologySan Giovanni-Addolorata HospitalRomeItaly
  2. 2.CLI FoundationRomeItaly

Personalised recommendations